BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34687144)

  • 1. SC66 inhibits the proliferation and induces apoptosis of human bladder cancer cells by targeting the AKT/β-catenin pathway.
    Chen W; Zhao S; Yu W; Rao T; Ruan Y; Zhu S; Xia Y; Song H; Cheng F
    J Cell Mol Med; 2021 Nov; 25(22):10684-10697. PubMed ID: 34687144
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic activity of the novel small molecule AKT inhibitor SC66 in hepatocellular carcinoma cells.
    Cusimano A; Puleio R; D'Alessandro N; Loria GR; McCubrey JA; Montalto G; Cervello M
    Oncotarget; 2015 Jan; 6(3):1707-22. PubMed ID: 25596737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Akt inhibitor SC66 promotes cell sensitivity to cisplatin in chemoresistant ovarian cancer cells through inhibition of COL11A1 expression.
    Wu YH; Huang YF; Chen CC; Chou CY
    Cell Death Dis; 2019 Apr; 10(4):322. PubMed ID: 30975980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deactivation of Akt by a small molecule inhibitor targeting pleckstrin homology domain and facilitating Akt ubiquitination.
    Jo H; Lo PK; Li Y; Loison F; Green S; Wang J; Silberstein LE; Ye K; Chen H; Luo HR
    Proc Natl Acad Sci U S A; 2011 Apr; 108(16):6486-91. PubMed ID: 21464312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic value of SC66 in human renal cell carcinoma cells.
    Xu M; Wang Y; Zhou LN; Xu LJ; Jin ZC; Yang DR; Chen MB; Zhu J
    Cell Death Dis; 2020 May; 11(5):353. PubMed ID: 32393791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Knockdown of TRIM26 inhibits the proliferation, migration and invasion of bladder cancer cells through the Akt/GSK3β/β-catenin pathway.
    Xie X; Li H; Pan J; Han X
    Chem Biol Interact; 2021 Mar; 337():109366. PubMed ID: 33549581
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AKT Inhibitor SC66 Inhibits Proliferation and Induces Apoptosis in Human Glioblastoma Through Down-Regulating AKT/β-Catenin Pathway.
    Gao L; Liu J; Xu P; Deng G; Liu B; Yuan F; Tan Y; Sun Q; Xu Y; Zhang H; Qi Y; Han S; Yang K; Geng R; Jiang H; Chen Q
    Front Pharmacol; 2020; 11():1102. PubMed ID: 32848734
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 9. Knockdown of Trop2 inhibits proliferation and migration and induces apoptosis of endometrial cancer cells via AKT/β-catenin pathway.
    Sun X; Xing G; Zhang C; Lu K; Wang Y; He X
    Cell Biochem Funct; 2020 Mar; 38(2):141-148. PubMed ID: 31967350
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Danusertib, a potent pan-Aurora kinase and ABL kinase inhibitor, induces cell cycle arrest and programmed cell death and inhibits epithelial to mesenchymal transition involving the PI3K/Akt/mTOR-mediated signaling pathway in human gastric cancer AGS and NCI-N78 cells.
    Yuan CX; Zhou ZW; Yang YX; He ZX; Zhang X; Wang D; Yang T; Pan SY; Chen XW; Zhou SF
    Drug Des Devel Ther; 2015; 9():1293-318. PubMed ID: 25767376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiproliferative factor decreases Akt phosphorylation and alters gene expression via CKAP4 in T24 bladder carcinoma cells.
    Shahjee HM; Koch KR; Guo L; Zhang CO; Keay SK
    J Exp Clin Cancer Res; 2010 Dec; 29(1):160. PubMed ID: 21143984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palbociclib, a selective CDK4/6 inhibitor, restricts cell survival and epithelial-mesenchymal transition in Panc-1 and MiaPaCa-2 pancreatic cancer cells.
    Rencuzogulları O; Yerlikaya PO; Gürkan AÇ; Arısan ED; Telci D
    J Cell Biochem; 2020 Jan; 121(1):508-523. PubMed ID: 31264276
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin inhibits β-catenin/ZEB1 signaling and suppresses bladder cancer metastasis via dual-blocking epithelial-mesenchymal transition and stemness.
    Wu K; Ning Z; Zeng J; Fan J; Zhou J; Zhang T; Zhang L; Chen Y; Gao Y; Wang B; Guo P; Li L; Wang X; He D
    Cell Signal; 2013 Dec; 25(12):2625-33. PubMed ID: 24012496
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isoflurane promotes epithelial-to-mesenchymal transition and metastasis of bladder cancer cells through HIF-1α-β-catenin/Notch1 pathways.
    Lu N; Piao MH; Feng CS; Yuan Y
    Life Sci; 2020 Oct; 258():118154. PubMed ID: 32735882
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Secalonic Acid-F, a Novel Mycotoxin, Represses the Progression of Hepatocellular Carcinoma via MARCH1 Regulation of the PI3K/AKT/β-catenin Signaling Pathway.
    Xie L; Li M; Liu D; Wang X; Wang P; Dai H; Yang W; Liu W; Hu X; Zhao M
    Molecules; 2019 Jan; 24(3):. PubMed ID: 30678274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-3β, Snail1, and β-catenin in renal proximal tubule cells.
    Lee YJ; Han HJ
    Am J Physiol Renal Physiol; 2010 May; 298(5):F1263-75. PubMed ID: 20015942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of valproic acid induced EMT by AKT/GSK3β/β-catenin signaling pathway in triple negative breast cancer.
    Ozman Z; Ozbek Iptec B; Sahin E; Guney Eskiler G; Deveci Ozkan A; Kaleli S
    Mol Biol Rep; 2021 Feb; 48(2):1335-1343. PubMed ID: 33515347
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired resistance to BRAF inhibition induces epithelial-to-mesenchymal transition in BRAF (V600E) mutant thyroid cancer by c-Met-mediated AKT activation.
    Byeon HK; Na HJ; Yang YJ; Ko S; Yoon SO; Ku M; Yang J; Kim JW; Ban MJ; Kim JH; Kim DH; Kim JM; Choi EC; Kim CH; Yoon JH; Koh YW
    Oncotarget; 2017 Jan; 8(1):596-609. PubMed ID: 27880942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Danusertib Induces Apoptosis, Cell Cycle Arrest, and Autophagy but Inhibits Epithelial to Mesenchymal Transition Involving PI3K/Akt/mTOR Signaling Pathway in Human Ovarian Cancer Cells.
    Zi D; Zhou ZW; Yang YJ; Huang L; Zhou ZL; He SM; He ZX; Zhou SF
    Int J Mol Sci; 2015 Nov; 16(11):27228-51. PubMed ID: 26580601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CRYAB inhibits migration and invasion of bladder cancer cells through the PI3K/AKT and ERK pathways.
    Ruan H; Li Y; Wang X; Sun B; Fang W; Jiang S; Liang C
    Jpn J Clin Oncol; 2020 Mar; 50(3):254-260. PubMed ID: 31829429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.